Results 71 to 80 of about 20,141 (153)

Primary structure of a potassium channel toxin from the sea anemone Actinia equina

, 1998
A potassium channel toxin (AeK) was isolated from the sea anemone Actinia equina by gel filtration on Sephadex G-50 and reverse-phase HPLC on TSKgel ODS-120T. AeK and α-dendrotoxin inhibited the binding of 125I-α-dendrotoxin to rat synaptosomal membranes
Minagawa, Sonomi, Ishida, Masami, Shiomi, Kazuo, Yuji Nagashima, Nagashima, Yuji, Sonomi Minagawa, Kazuo Shiomi, Masami Ishida   +7 more
core   +1 more source

Esters biotransformation by immobilized interfacial esterases from the Caribbean Sea anemone : Stichodactyla helianthus

, 2015
An immobilized biocatalyst (ShIE-Octyl) was obtained by interfacial adsorption on Octyl-Sepharose CL 4B sup-port of all interfacial esterases from the aqueous extract of the sea anemone Stichodactyla helianthus. ShIE-Octyl, synthesized by this simple method, contains semipurified interfacial esterases, including the isotoxins StI and StII.
Monte-Martínez, Alberto del, González-Bacerio, J., Cutiño-Avila, Bessy, Ruiz, R., Ávila, R., Ramos-Leal, M., Nolasco, H., Díaz, J., Guisán, José Manuel   +8 more
openaire   +1 more source

INTERSpECIFIC vARIATION IN ANEMONE ShRIMp dISTRIBUTION ANd hOST SELECTION IN ThE FLORIdA KEyS (USA): IMpLICATIONS FOR MARINE CONSERvATION

, 2008
Host and symbiont abundances often depend on the degree of host specificity and differences in costs and benefits of these associations. In this study, we investigated the distribution of anemone shrimps and their hosts along with the shrimps' host ...
Silbiger, Nyssa, Childress, Michael
core   +1 more source

The Mitochondrial Genome of the Sea Anemone Stichodactyla haddoni Reveals Catalytic Introns, Insertion-Like Element, and Unexpected Phylogeny. [PDF]

Life (Basel), 2021
Johansen SD, Chi SI, Dubin A, Jørgensen TE.   +3 more
europepmc   +1 more source

Multiomic Approach for Bioprospection: Investigation of Toxins and Peptides of Brazilian Sea Anemone Bunodosoma caissarum. [PDF]

Mar Drugs, 2023
Mazzi Esquinca ME, Correa CN, Marques de Barros G, Montenegro H, Mantovani de Castro L.   +4 more
europepmc   +1 more source

Contribución al mecanismo de formación de poros de sticholisina I, una proteína formadora de poros de la anémona Stichodactyla helianthus, mediante el empleo de mutantes de Cys en zonas funcionalmente relevantes de la proteína

, 2016
Sticholisina I (St I) es una citolisina producida por la anémona marina Stichodactyla helianthus, que se caracteriza por formar poros oligoméricos en membranas naturales y artificiales.
M.Cilli, Eduardo, Schreier, Shirley, Morera Córdova, Vivian, Alvarado Mesén, Javier, Pazos Santos, Isabel Fabiola, Escalona Rodríguez, Felipe Adonis, Lanio Ruiz, María Eliana, Díaz, Iscel, Pérez Barzaga, Víctor, R.G. Barbosa, Joao Alexandre, Pentón, David, Álvarez Valcárcel, Carlos, Fando, Rafael, Pons Hernández, Tirso, de la Patria Hervis, Yadira, Ndapewa Amapindi, Frieda Aina, Calderón Jiménez, Lesly, Martínez Cruz-Bustillo, Diana, Pupo Meriño, Amaury, Dyszy, Fabio, López Castillo, Aracelys, Valle Garay, Aisel, Tejuca Martínez, Mayra, del Valle García, Rubén, Lissi, Eduardo, Castellanos-Serra, Lila R., Pérez Socas, Luis Benito, de Armas Guitart, German, Calvo, Loany, Ramírez Ramírez, Ángel Rafael, Canet Santos, Liem, Campos Gómez, Javier, Pedrera Puentes, Lohans, Reytor González, Mey Ling, Horjales, Eduardo   +34 more
core  

Is Proteolytic Cleavage Essential for the Enhanced Activity of Hydra Pore-Forming Toxin, HALT-4? [PDF]

Toxins (Basel), 2023
Yap WY, Hwang JS.
europepmc   +1 more source

anticorpo murino monoclonale diretto contro una tossina emolitica dell'attinia Stichodactyla helianthus

, 2007
CANNATA, STEFANO, DESIDERI, ALESSANDRO, RUFINI, STEFANO   +2 more
openaire   +2 more sources

Never, Ever Make an Enemy… Out of an Anemone: Transcriptomic Comparison of Clownfish Hosting Sea Anemone Venoms. [PDF]

Mar Drugs, 2022
Delgado A, Benedict C, Macrander J, Daly M.   +3 more
europepmc   +1 more source

Natural Inhibitors of Mammalian α-Amylases as Promising Drugs for the Treatment of Metabolic Diseases. [PDF]

Int J Mol Sci, 2023
Kalinovskii AP, Sintsova OV, Gladkikh IN, Leychenko EV.   +3 more
europepmc   +1 more source